Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters.

ABSTRACT:

Background

The third fatal coronavirus is the novel coronavirus (SARS-CoV-2) that causes novel coronavirus pneumonia (COVID-19) which first broke out in December 2019. Patients will develop rapidly if there is no any intervention, so the risk identification of severe patients is critical. The aim of this study was to investigate the characteristics and rules of hematology changes in patients with COVID-19, and to explore the possibility differentiating moderate and severe patients using conventional hematology parameters or combined parameters.

Methods

The clinical data of 45 moderate and severe type patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in Jingzhou Central Hospital from January 23 to February 13, 2020 were collected. The epide

SUBMITTER: Wang C 

PROVIDER: S-EPMC7290538 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature